FLML Key Stats
- Flamel Technologies Announces Product Partnership Agreement Marketwired Jun 6
- Nasdaq stocks posting largest volume increases Jun 4
- Nasdaq stocks posting largest percentage increases Jun 4
- Flamel Tech rises to annual high on drug approval Jun 3
- Flamel (FLMML) Bloxiverz NDA Approved by U.S. FDA Street Insider Jun 3
- Flamel Technologies Announces FDA Approval of Bloxiverz Marketwired Jun 3
- Nasdaq stocks posting largest percentage increases May 29
- Flamel Technologies Obtains Rights to Two Molecules of Trigger Lock Product Line Marketwired May 23
- Flamel Technologies S.A. Shares Cross Below 200 DMA May 9
- Flamel Technologies' CEO Discusses Q1 2013 Results - Earnings Call Transcript Seeking Alpha May 7
FLML Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Flamel Technologies is up 50.00% over the last year vs S&P 500 Total Return up 23.89%, ACADIA Pharmaceuticals up 1082%, and Albany Molecular Research up 348.9%.
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Pro Ratings for FLML
Pro Report PDF for FLML
Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.Download FLML Pro Report PDF
Pro Strategies Featuring FLML
Did Flamel Technologies make it into our Pro Portfolio Strategies?
Start your YCharts Pro membership now to find out.